Outsourced Pharma White Papers
-
If You Can't Win The Game, Change It
12/11/2024
Explore how eData sharing is used in the biopharma market, enabling standardized, collaborative supply chains that reduce risks and enhance visibility while improving capacity planning.
-
Economic Advantage Of Robotic Gloveless Pharmaceutical Isolators
4/28/2025
Are robotic gloveless isolators the key to smarter, safer, scalable solutions? Discover how they can revolutionize aseptic filling by reducing contamination, minimizing waste, and enhancing manufacturing flexibility.
-
Expanding The Capabilities Of Targeted Integration
5/1/2026
See the demonstration of precise, site‑specific integration of a 50 kb multi‑gene construct into human iPSCs, overcoming size limits of traditional genome‑engineering approaches.
-
Enabling Digital Twins With Computational Fluid Dynamics Modeling
1/16/2025
Embrace the transformative power of predictive modeling and digital twin technology to optimize bioprocess efficiency, ensure product quality, and drive innovation in biopharmaceutical manufacturing.
-
Overcoming The Obstacles Of Spray-Dried Dispersion Scale-Up
9/9/2026
SDD scale-up introduces scale-dependent risks that threaten bioavailability, stability, and manufacturability. This white paper details a model-based framework for managing those risks from early feasibility through commercial production.
-
Molecular Properties Of PROTACs And The Relationship To Formulation Design
3/4/2025
Here, we conduct a comprehensive analysis of diverse PROTAC (Proteolysis Targeting Chimeras) structures, evaluating their calculated physicochemical properties to identify key trends.
-
The Value Of Engaging A Single CDMO For Comprehensive Biologics Services
2/4/2026
By forging strategic partnerships with comprehensive CDMOs, see how emerging biopharma firms can navigate through early-phase development and ensure a smooth transition to clinical advancement.
-
The Importance Of Polymorph Screenings
5/6/2026
Discover how systematic polymorph screening reduces development risk, safeguards product performance, and enables confident solid‑form selection across the drug development lifecycle.
-
Performance Characteristics Of The Mobius® ADC Reactor For Conjugation
10/22/2024
Explore results from a series of studies evaluating the mixing performance of an innovative ADC reactor during the conjugation step utilizing a model fluid.
-
Vial Breakage During Lyophilization: Root Causes And Mitigation
10/16/2024
Learn how controlling freezing rates, using specialized vials, and employing optimized stoppering techniques can reduce the risk of vial breakage during lyophilization and ensure high product quality.